NCT02864992 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 152
- group Id
- BG001
- value
- 24
- group Id
- BG002
- value
- 161
- group Id
- BG003
- value
- 337
- units
- Participants
- groups
- description
- Participants received 500 milligram (mg) of tepotinib once daily in cycles of 21-day duration until disease progression, death, adverse event (AE) leading to discontinuation or withdrawal of consent.
- id
- BG000
- title
- Part 1: Cohort A: METex14 Skipping Alterations
- description
- Participants received 500 milligram (mg) of tepotinib once daily in cycles of 21-day duration until disease progression, death, adverse event (AE) leading to discontinuation or withdrawal of consent.
- id
- BG001
- title
- Part 1: Cohort B: MET Amplification
- description
- Participants received 500 milligram (mg) of tepotinib once daily in cycles of 21-day duration until disease progression, death, adverse event (AE) leading to discontinuation or withdrawal of consent.
- id
- BG002
- title
- Part 2: Cohort C: Confirmatory Part for METex14 Skipping Alterations
- description
- Total of all reporting groups
- id
- BG003
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 8.97
- value
- 73.0
- group Id
- BG001
- spread
- 9.17
- value
- 62.3
- group Id
- BG002
- spread
- 9.24
- value
- 71.5
- group Id
- BG003
- spread
- 9.47
- value
- 71.5
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 73
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 86
- group Id
- BG003
- value
- 162
- title
- Female
- measurements
- group Id
- BG000
- value
- 79
- group Id
- BG001
- value
- 21
- group Id
- BG002
- value
- 75
- group Id
- BG003
- value
- 175
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 3
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 148
- group Id
- BG001
- value
- 23
- group Id
- BG002
- value
- 157
- group Id
- BG003
- value
- 328
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 6
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 38
- group Id
- BG001
- value
- 07
- group Id
- BG002
- value
- 68
- group Id
- BG003
- value
- 113
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 01
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 02
- group Id
- BG003
- value
- 3
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 108
- group Id
- BG001
- value
- 17
- group Id
- BG002
- value
- 87
- group Id
- BG003
- value
- 212
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 05
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 04
- group Id
- BG003
- value
- 9
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- population Description
- All participants in Cohort A, Cohort B and Cohort C who were administered at least 1 dose of tepotinib.
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 152
- group Id
- BG001
- value
- 24
- group Id
- BG002
- value
- 161
- group Id
- BG003
- value
- 337
- units
- Participants
- groups
- description
- Participants received 500 milligram (mg) of tepotinib once daily in cycles of 21-day duration until disease progression, death, adverse event (AE) leading to discontinuation or withdrawal of consent.
- id
- BG000
- title
- Part 1: Cohort A: METex14 Skipping Alterations
- description
- Participants received 500 milligram (mg) of tepotinib once daily in cycles of 21-day duration until disease progression, death, adverse event (AE) leading to discontinuation or withdrawal of consent.
- id
- BG001
- title
- Part 1: Cohort B: MET Amplification
- description
- Participants received 500 milligram (mg) of tepotinib once daily in cycles of 21-day duration until disease progression, death, adverse event (AE) leading to discontinuation or withdrawal of consent.
- id
- BG002
- title
- Part 2: Cohort C: Confirmatory Part for METex14 Skipping Alterations
- description
- Total of all reporting groups
- id
- BG003
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 8.97
- value
- 73.0
- group Id
- BG001
- spread
- 9.17
- value
- 62.3
- group Id
- BG002
- spread
- 9.24
- value
- 71.5
- group Id
- BG003
- spread
- 9.47
- value
- 71.5
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 73
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 86
- group Id
- BG003
- value
- 162
- title
- Female
- measurements
- group Id
- BG000
- value
- 79
- group Id
- BG001
- value
- 21
- group Id
- BG002
- value
- 75
- group Id
- BG003
- value
- 175
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 3
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 148
- group Id
- BG001
- value
- 23
- group Id
- BG002
- value
- 157
- group Id
- BG003
- value
- 328
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 6
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 38
- group Id
- BG001
- value
- 07
- group Id
- BG002
- value
- 68
- group Id
- BG003
- value
- 113
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 01
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 02
- group Id
- BG003
- value
- 3
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 108
- group Id
- BG001
- value
- 17
- group Id
- BG002
- value
- 87
- group Id
- BG003
- value
- 212
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 05
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 04
- group Id
- BG003
- value
- 9
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- population Description
- All participants in Cohort A, Cohort B and Cohort C who were administered at least 1 dose of tepotinib.
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle